Chetan B. Sangani

Design, synthesis and molecular modeling of pyrazole–quinoline–pyridine hybrids as a new class of antimicrobial and anticancer agents

Chetan B. Sangani, Jigar A. Makawana, Xin Zhang et al. · European Journal of Medicinal Chemistry · 2014 · 125 citations · Full text

Medicinal Chemistry, Antimicrobial Drug Discovery, Medicine +11

Microwave assisted synthesis of novel 4h-chromene derivatives bearing phenoxypyrazole and their antimicrobial activity assess

Chetan B. Sangani, Nimesh Shah, Manish P. Patel et al. · Journal of the Serbian Chemical Society · 2012 · 69 citations · Full text

Organic Chemistry, New Series, Antimicrobial Chemotherapy +17

Synthesis, biological evaluation and 3D-QSAR study of novel 4,5-dihydro-1H-pyrazole thiazole derivatives as BRAFV600E inhibitors

Mengyue Zhao, Yong Yin, Xiao‐Wei Yu et al. · Bioorganic & Medicinal Chemistry · 2014 · 67 citations

Medicinal Chemistry, Brafv600e Inhibitors, Medicine +9

Schiff’s base derivatives bearing nitroimidazole and quinoline nuclei: New class of anticancer agents and potential EGFR tyrosine kinase inhibitors

Jigar A. Makawana, Chetan B. Sangani, Lin Lin et al. · Bioorganic & Medicinal Chemistry Letters · 2014 · 55 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Quinoline Nuclei +13

Synthesis and in vitro antimicrobial screening of new pyrano[4,3-b]pyrane derivatives of 1H-pyrazole

Chetan B. Sangani, Divyesh C. Mungra, Manish P. Patel et al. · Chinese Chemical Letters · 2011 · 43 citations

Medicinal Chemistry, Antimicrobial Drug Discovery, Bioorganic Chemistry +9